Workflow
aTyr Pharma(LIFE)
icon
Search documents
Neotech Metals Announces Amended LIFE Financing
Newsfile· 2024-08-14 01:54
Core Viewpoint - Neotech Metals Corp. has amended the terms of its non-brokered private placement LIFE financing, aiming to raise between $1,350,000 and $2,500,000 through the issuance of units priced at $0.15 each, which include common shares and warrants [1][5]. Group 1: Offering Details - The offering will consist of a minimum of 9,000,000 units and up to a maximum of 16,666,667 units, with each unit comprising one common share and one warrant [1]. - Each warrant allows the holder to purchase an additional common share at a price of $0.25 for a period of 36 months from issuance [1]. - An acceleration provision is included, allowing the company to shorten the expiry date of the warrants to 30 days if the closing price of the common shares exceeds $0.50 for 10 consecutive trading days [2]. Group 2: Compensation and Regulatory Compliance - The company may pay finders a cash commission of up to 7% of the total gross proceeds raised and issue finder's warrants equivalent to 7% of the total units subscribed [3]. - The offering will be available to purchasers in all provinces of Canada except Quebec, under the listed issuer financing exemption, and the securities will not be subject to resale restrictions [4]. Group 3: Use of Proceeds - The net proceeds from the offering will be allocated for exploration expenditures and general corporate operating expenses [5]. Group 4: Company Overview - Neotech Metals Corp. is focused on mineral exploration, particularly in rare earth elements, with properties located in British Columbia and Ontario [6][7].
GLOBE LIFE INC. REPORTS SECOND QUARTER 2024 RESULTS
Prnewswire· 2024-07-24 20:15
| --- | --- | --- | --- | --- | --- | --- | |--------------------|--------------------------|--------------|-------|---------------|--------------|--------| | | June 30, 2024 \nAmount | % of Premium | | 2023 \nAmount | % of Premium | % Chg. | | United American | $ 16,571 | 11 | | $ 14,753 | 11 | 12 | | | | | | | | | | Family Heritage | 36,611 | 35 | | 32,704 | 33 | 12 | | Liberty National | 26,400 | 55 | | 26,208 | 56 | 1 | | American Income | 19,092 | 62 | | 18,169 | 62 | 5 | | Direct to Consumer | 1,814 | ...
GLOBE LIFE INC. ANNOUNCES SECOND QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
Prnewswire· 2024-07-11 21:17
1-786-697-3501 Listen live and as a replay at https://investors.globelifeinsurance.com/ under Calls and Meetings Globe Life Inc. is a holding company specializing in life and supplemental health insurance for the middleincome market distributed through multiple channels, including direct to consumer and exclusive and independent agencies. Second Quarter Conference Call Thursday, July 25, 2024 11:00am (Eastern) (Passcode: Globe Life Inc.) MCKINNEY, Texas, July 11, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE: ...
Neotech Metals Announces LIFE Financing
Newsfile· 2024-06-24 08:00
Core Viewpoint - Neotech Metals Corp. is initiating a non-brokered private placement financing to raise between $1,500,000 and $2,500,000 through the sale of units priced at $0.25 each, aimed at funding exploration and operational expenses [1][3]. Group 1: Offering Details - The offering will consist of a minimum of 6,000,000 units and up to 10,000,000 units, with each unit comprising one common share and one warrant [1]. - Each warrant allows the holder to purchase an additional common share at a price of $0.35 for a period of 36 months from issuance [1]. - The company may pay finders a cash commission of up to 7% of the gross proceeds and issue finder's warrants equivalent to 7% of the total units subscribed [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for exploration expenditures and general corporate operating expenses [3]. Group 3: Company Background - Neotech Metals Corp. is focused on mineral exploration, owning 100% of its TREO Rare Earth Element Property and Foothills Rare Earth Element Property in British Columbia [15].
GLOBE LIFE, INC. INVESTORS: Pending Lead Plaintiff Deadline in GL Securities Fraud Class Action; Stockholders Should Contact Robbins LLP for Information
GlobeNewswire News Room· 2024-06-20 17:19
Core Viewpoint - Globe Life, Inc. is facing a class action lawsuit due to allegations of widespread insurance fraud and a hostile workplace environment, which has significantly impacted its stock price [3][8]. Group 1: Company Overview - Globe Life, Inc., formerly known as Torchmark Corporation, is an insurance company that provides a variety of insurance products, including life insurance, mortgage protections, and supplemental health insurance [7]. - The company operates five wholly owned insurance subsidiaries, with the Income Life Insurance Company (AIL) being the largest, contributing 50% of the company's profits in 2022 and 2023 [1][7]. Group 2: Allegations and Impact - The complaint alleges that Globe Life engaged in insurance fraud by underwriting policies for deceased and fictitious individuals and adding policies to existing users' accounts without their consent [3]. - The investment research firm Fuzzy Panda reported that Globe Life allowed a culture of unchecked sexual harassment and maintained a hostile workplace environment, violating the company's Code of Conduct [3]. - Following these allegations, Globe Life's stock price plummeted by $55.76, or 53%, from $104.93 per share on April 10, 2024, to $49.17 per share on April 11, 2024 [8]. Group 3: Legal Proceedings - A class action lawsuit has been filed on behalf of all individuals and entities that purchased Globe Life common stock between May 8, 2019, and April 10, 2024 [7]. - Shareholders interested in serving as lead plaintiffs must file their motions by July 1, 2024 [4].
Cruz Closes $225,000 Listed Issuer Financing Exemption (LIFE) Private Placement
Newsfile· 2024-06-10 22:33
The units sold under the Offering were issued and sold pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 Prospectus Exemptions (the "Listed Issuer Financing Exemption"). A copy of the offering document under the Listed Issuer Financing Exemption dated May 30, 2024 is available under the Company's profile at www.sedarplus.ca and on the Company's website at www.cruzbatterymetals.com. All units issued pursuant to the Listed Issuer Financing Exemption are not subject ...
BMEX Gold Announces Listed Issuer Financing Exemption (LIFE) Financing for Non-Brokered Private Placement
Newsfile· 2024-06-10 11:00
. . June 10, 2024 7:00 AM EDT | Source: BMEX Gold Inc The Offering will consist of the sale of a minimum of 2,000,000 non-flow-through units ("NFT Units") at $0.15 per NFT Unit for gross non-flow-through proceeds of $300,000, and will also include a maximum of up to 6,666,667 flow-through units ("FT Unit") at $0.15 per FT Unit for gross flow-through proceeds of up to $1,000,000. Each FT Unit and each NFT Unit consists of one common share (a "Common Share") of the Company and one full common share purchase w ...
GLOBE LIFE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Globe Life Inc. – GL
GlobeNewswire News Room· 2024-06-06 02:57
NEW ORLEANS, June 05, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 1, 2024 to file lead plaintiff applications in a securities class action lawsuit against Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL), if they purchased or otherwise acquired the Company's shares between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"). Long term holders of GL are also encouraged to contact the firm. This action is pending in ...
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from "LIFE" to "ATYR"
Newsfilter· 2024-06-03 12:00
Company Overview - aTyr Pharma, Inc. is a clinical stage biotechnology company focused on discovering and developing first-in-class medicines from its proprietary tRNA synthetase platform [1][2] - The company is advancing its lead therapeutic candidate, efzofitimod, through a pivotal Phase 3 study in pulmonary sarcoidosis, with potential commercialization on the horizon [1][2] Ticker Symbol Change - The company will change its ticker symbol from "LIFE" to "ATYR," effective June 5, 2024, to better reflect its corporate identity and enhance visibility [1] - Existing stockholders do not need to take any action regarding the ticker symbol change, and the common stock will continue to be listed on the Nasdaq Capital Market [1] Therapeutic Focus - aTyr's lead candidate, efzofitimod, is a first-in-class biologic immunomodulator in clinical development for treating interstitial lung disease, which includes immune-mediated disorders causing lung inflammation and progressive fibrosis [2]
Cruz Announces $225,000 Listed Issuer Financing Exemption (LIFE) Private Placement
Newsfile· 2024-05-30 20:45
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - Cruz Battery Metals Corp. (CSE: CRUZ) (OTC Pink: BKTPF) (FSE: A3CWU7) ("Cruz" or the "Company") has arranged a non-brokered listed issuer financing exemption (LIFE) private placement of up to 6,250,000 units at a price of $0.036 per unit. Each unit will comprise of one common share of the Company and one share purchase warrant to purchase one common share of the Company at a price of $0.05 for a period of 60 months from the Closing Date. The Off ...